Leslie M. Magnus
Corporate Officer/Principal chez SYNERGY PHARMACEUTICALS INC
Profil
Leslie M.
Magnus is currently the Senior Vice President-Medical Affairs at Synergy Pharmaceuticals LLC since 2015.
Previously, Magnus worked as the Vice President-Medical Affairs at UCB Pharma, Inc. Magnus completed an undergraduate degree at Brown University and a graduate degree at Albany State University (Georgia).
Postes actifs de Leslie M. Magnus
| Sociétés | Poste | Début |
|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2015 |
Anciens postes connus de Leslie M. Magnus
| Sociétés | Poste | Fin |
|---|---|---|
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Directeur Technique/Scientifique/R&D | - |
Formation de Leslie M. Magnus
| Brown University | Undergraduate Degree |
| Albany State University (Georgia) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
